1. Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study. Issue 9 (16th October 2020) Authors: Piazza, M.; Hanssen, N. M. J.; Persson, F.; Scheijen, J. L.; van de Waarenburg, M. P. H.; van Greevenbroek, M. M. J.; Rossing, P.; Hovind, P.; Stehouwer, C. D. A.; Parving, H‐H.; Schalkwijk, C. G. Journal: Diabetic medicine Issue: Volume 38:Issue 9(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗